SCHEMBL2662702

SCHEMBL2662702

CS(=O)(=O)c1ccc(Oc2ccccc2C(N)=O)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTNNB1 P35222 1/20 0.66
PTGS2 P35354 1/20 0.52
IRAK4 Q9NWZ3 1/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
NR1I2 O75469 1/20 0.46
LMNA P02545 1/20 0.46
CHRM2 P08172 1/20 0.46
CYP3A4 P08684 1/20 0.46
ADRA2A P08913 1/20 0.46
MAPT P10636 1/20 0.46
OPRK1 P41145 1/20 0.46
HTR2B P41595 1/20 0.46
SLC6A3 Q01959 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
BRD4 O60885 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
PARP10 Q53GL7 1/20 0.44
SLC6A4 P31645 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7689367 0.86 CTNNB1 (0.68) CTNNB1IRAK4MEN1KMT2ANR1I2
SCHEMBL6368241 0.81 CTNNB1 (0.74) CTNNB1IRAK4MEN1KMT2ANR1I2
Methyl Alcohol SCHEMBL8782982 0.80 CTNNB1 (0.93) CTNNB1IRAK4MEN1KMT2ANR1I2
SCHEMBL27680126 0.80 CTNNB1 (1.00) CTNNB1IRAK4MEN1KMT2ANR1I2
SCHEMBL5724 0.80 CTNNB1 (1.00) CTNNB1IRAK4MEN1KMT2ANR1I2
SCHEMBL28876495 0.80 CTNNB1 (1.00) CTNNB1IRAK4MEN1KMT2ANR1I2
SCHEMBL14030895 0.79 HTT (0.68) PTGS2MEN1KMT2ALMNAL3MBTL1
SCHEMBL1892492 0.79 CTNNB1 (0.77) CTNNB1IRAK4MEN1KMT2ANR1I2
SCHEMBL27800575 0.79 CTNNB1 (0.77) CTNNB1IRAK4MEN1KMT2ANR1I2
SCHEMBL16041713 0.79 BRD4 (0.78) CTNNB1PTGS2BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2027113-A1 HETEROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES AstraZeneca AB (SE) 2009-02-25 EP disclosed
WO-2007007042-A1 HETEROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES ASTRAZENECA AB (SE) 2007-01-18 WO disclosed
CN-1777589-A Heteroarylcarbamoylbenzene derivatives BANYU PHARMA CO LTD (JP) 2006-05-24 CN disclosed